Skip to main content
. 2020 Mar 20;18:58. doi: 10.1186/s12957-020-01833-8

Fig. 1.

Fig. 1

Hazard ratio plots to determine optimal lymph node (LN) cut-offs for disease-free survival (DFS) and overall survival (OS) in the neoadjuvant chemoradiotherapy (NACRT) group. a Hazard ratio plot for DFS (LN cut-off 16.5). b Hazard ratio plot for OS (LN cut-off 8.5)